Astonea Labs

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0TG901011
  • NSEID:
  • BSEID: 544409
INR
156.00
0.00 (0.00%)
BSENSE

Jan 30

BSE+NSE Vol: 2000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 21.61% vs 19.60% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 26.95% vs 67.07% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 23.53% vs 27.35% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 31.46% vs 511.86% in Mar 2024

Compare Profit and Loss Results of Astonea Labs
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
97.00
167.00
-70.00
-41.92%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
97.00
167.00
-70.00
-41.92%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
66.00
85.00
-19.00
-22.35%
Power & Fuel Cost
1.00
15.00
-14.00
-93.33%
Employee Cost
6.00
13.00
-7.00
-53.85%
Operating Expenses
5.00
13.00
-8.00
-61.54%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
14.00
-14.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
1.00
-1.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
82.00
148.00
-66.00
-44.59%
Operating Profit (PBDIT) excl Other Income
15.00
19.00
-4.00
-21.05%
Other Income
0.00
4.00
-4.00
-100.00%
Operating Profit (PBDIT)
15.00
23.00
-8.00
-34.78%
Interest
3.00
6.00
-3.00
-50.00%
Profit before Depriciation and Tax
11.00
17.00
-6.00
-35.29%
Depreciation
4.00
8.00
-4.00
-50.00%
Profit Before Taxation & Exceptional Items
7.00
9.00
-2.00
-22.22%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
7.00
9.00
-2.00
-22.22%
Provision for Tax
1.00
2.00
-1.00
-50.00%
Profit After Tax
5.00
6.00
-1.00
-16.67%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
81.00
-77.00
-95.06%
Profit Available for appropriations
9.00
87.00
-78.00
-89.66%
Appropriations
9.00
87.00
-78.00
-89.66%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
6.94
6.43
0.51
7.93%
Profit And Loss - Net Sales
Net Sales 97.52 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 21.61% vs 19.60% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.12 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 26.95% vs 67.07% in Mar 2024

Profit And Loss - Interest
Interest 3.66 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 23.53% vs 27.35% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 5.35 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 31.46% vs 511.86% in Mar 2024